Zhongchao PE Ratio 2019-2025 | ZCMD

Current and historical p/e ratio for Zhongchao (ZCMD) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zhongchao PE ratio as of November 11, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Zhongchao PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-11-11 0.70 0.00
2025-06-30 1.21 0 0.00
2024-12-31 1.62 0 0.00
2024-06-30 1.32 0 0.00
2023-12-31 3.51 0 0.00
2023-06-30 12.00 0 0.00
2022-12-31 11.49 0 0.00
2022-06-30 12.96 0 0.00
2021-12-31 17.80 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.017B $0.016B
Zhongchao Inc. is a provider of healthcare information, professional training and educational services to healthcare professionals under its MDMOOC platform and to the public under its Sunshine Health Forums platform. Zhongchao Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.476B 59.15
Tempus AI (TEM) United States $12.470B 0.00
Doximity (DOCS) United States $9.841B 40.73
Hims & Hers Health (HIMS) United States $9.345B 76.02
IRhythm Technologies (IRTC) United States $5.680B 0.00
Hinge Health (HNGE) United States $3.475B 0.00
Privia Health (PRVA) United States $2.879B 180.08
Heartflow (HTFL) United States $2.821B 0.00
Inspire Medical Systems (INSP) United States $2.501B 41.38
10x Genomics (TXG) United States $2.126B 0.00
Enovis (ENOV) United States $1.731B 9.09
Omnicell (OMCL) United States $1.652B 33.77
Azenta (AZTA) United States $1.387B 60.52
Phreesia (PHR) United States $1.355B 0.00
Schrodinger (SDGR) United States $1.346B 0.00
Clover Health Investments (CLOV) United States $1.333B 0.00
Claritev (CTEV) United States $0.953B 0.00
Fulgent Genetics (FLGT) United States $0.840B 0.00
Evolent Health (EVH) United States $0.582B 0.00
Butterfly Network (BFLY) United States $0.561B 0.00
Talkspace (TALK) United States $0.560B 112.67
Veradigm (MDRX) United States $0.517B 0.00
Standard BioTools (LAB) United States $0.450B 0.00
Carlsmed (CARL) United States $0.335B 0.00
Zepp Health (ZEPP) Netherlands $0.325B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.294B 0.00
TruBridge (TBRG) United States $0.286B 13.15
CapsoVision (CV) United States $0.231B 0.00
Outset Medical (OM) United States $0.214B 0.00
MDxHealth SA (MDXH) Belgium $0.210B 0.00
Health Catalyst (HCAT) United States $0.201B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.195B 0.00
Nyxoah SA (NYXH) Belgium $0.183B 0.00
KORU Medical Systems (KRMD) United States $0.181B 0.00
CareCloud (CCLD) United States $0.143B 7.84
EUDA Health Holdings (EUDA) Singapore $0.113B 0.00
Pulmonx (LUNG) United States $0.079B 0.00
NetraMark Holdings (AINMF) Canada $0.075B 0.00
American Well (AMWL) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
P3 Health Partners (PIII) United States $0.054B 0.00
Evaxion - (EVAX) Denmark $0.040B 0.00
111 (YI) China $0.036B 0.00
Precipio (PRPO) United States $0.033B 0.00
Predictive Oncology (POAI) United States $0.025B 0.00
Lunai Bioworks (LNAI) United States $0.021B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Movano (MOVE) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.000B 0.00